Skip to main content
Log in

Antibiotic resistance in E. coli isolates from patients with urinary tract infections presenting to the emergency department

  • Original Paper
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

Escherichia coli urine isolates from patients presenting to the emergency department at a German tertiary care hospital were retrospectively analyzed from January 2015–March 2017 to determine antibiotic resistance patterns and patient risk factors for resistance.

Methods

Uncomplicated urinary tract infection (UTI) was defined as UTI in the otherwise healthy patient without relevant co-morbidities and complications. Patients were assumed to have UTI if diagnosis was made by the attending physician with conclusive dipstick results. For subgroup analysis, only patients with symptoms suggestive for UTI documented in their records were included.

Results

228 patients with a UTI diagnosed by the attending physician with E. coli isolated in urine culture were included. 154/228 patients had documented symptomatic UTI, 57/154 had uncomplicated infection, 76/154 patients had cystitis, and 124/154 were female. Resistance rates of uncomplicated UTI in symptomatic patients were: ciprofloxacin 10.5%, cotrimoxazole 15.8%, amoxicillin/clavulanic acid 5.3%, nitrofurantoin 0% (CLSI MICs). Previous hospitalization in the last 3 months (including patients living in a long-term care facility) was significantly correlated with resistance to ciprofloxacin, cotrimoxazole and amoxicillin/clav. Previous hospitalization was a strong predictor of resistance to ciprofloxacin and cotrimoxazole in multivariate analysis also. Other risk factors correlated with resistance were hematological malignancy (for cotrimoxazole) and renal transplantation (for ciprofloxacin).

Conclusions

Cotrimoxazole is still an alternative for treating uncomplicated cystitis. Previous hospitalization in the last 3 months was a strong predictor of resistance to cotrimoxazole and ciprofloxacin. Other risk factors which might help guide empirical therapy are hematological malignancy and renal transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med. 2012;366:1028–37. https://doi.org/10.1056/NEJMcp1104429.

    Article  PubMed  CAS  Google Scholar 

  2. Kranz J, Schmidt S, Lebert C, Schneidewind L, Vahlensieck W, Sester U, et al. Epidemiologie, Diagnostik, Therapie, Pravention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten: Aktualisierung 2017 der interdisziplinaren AWMF S3Leitlinie. Urologe A. 2017. https://doi.org/10.1007/s00120-017-0389-1.

    Article  PubMed  Google Scholar 

  3. Wagenlehner FME, Niemetz A, Dalhoff A, Naber KG. Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994–2000. Int J Antimicrob Agents. 2002;19:557–64. https://doi.org/10.1016/S0924-8579(02)00100-0.

    Article  PubMed  CAS  Google Scholar 

  4. Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008;54:1164–75. https://doi.org/10.1016/j.eururo.2008.05.010.

    Article  PubMed  Google Scholar 

  5. Kresken M, Korber-Irrgang B, Biedenbach DJ, Batista N, Besard V, Canton R, et al. Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries. Clin Microbiol Infect. 2016;22:63.e1–5. https://doi.org/10.1016/j.cmi.2015.08.019.

  6. Schmiemann G, Gágyor I, Hummers-Pradier E, Bleidorn J. Resistance profiles of urinary tract infections in general practice—an observational study. BMC Urol. 2012;12:33. https://doi.org/10.1186/1471-2490-12-33.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Leitlinienprogramm DGU. Interdisziplinäre S3 Leitlinie: Epidemiologie, Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. Langversion 1.1–2, 2017 AWMF Registernummer: 043/044. http://www.awmf.org/uploads/tx_szleitlinien/043-044l_S3_Harnwegsinfektionen_2017-05.pdf.

  8. Nace DA, Drinka PJ, Crnich CJ. Clinical uncertainties in the approach to long term care residents with possible urinary tract infection. J Am Med Dir Assoc. 2014;15:133–9. https://doi.org/10.1016/j.jamda.2013.11.009.

    Article  PubMed  Google Scholar 

  9. Rossignol L, Vaux S, Maugat S, Blake A, Barlier R, Heym B, et al. Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study. Infection. 2017;45:33–40. https://doi.org/10.1007/s15010-016-0910-2.

    Article  PubMed  CAS  Google Scholar 

  10. Caron F, Wehrle V, Etienne M. The comeback of trimethoprim in France. Med Mal Infect. 2017;47:253–60. https://doi.org/10.1016/j.medmal.2016.12.001.

    Article  PubMed  CAS  Google Scholar 

  11. Sundqvist M, Geli P, Andersson DI, Sjölund-Karlsson M, Runehagen A, Cars H, et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother. 2010;65:350–60. https://doi.org/10.1093/jac/dkp387.

    Article  PubMed  CAS  Google Scholar 

  12. Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother. 2015;70:2456–64. https://doi.org/10.1093/jac/dkv147.

    Article  PubMed  CAS  Google Scholar 

  13. Smith SC, Bazzoli C, Chung I, Johnson A, Martin DR. Antimicrobial susceptibility of Escherichia coli in uncomplicated cystitis in the emergency department: is the hospital antibiogram an effective treatment guide? Acad Emerg Med. 2015;22:998–1000. https://doi.org/10.1111/acem.12729.

    Article  PubMed  Google Scholar 

  14. Zatorski C, Jordan JA, Cosgrove SE, Zocchi M, May L. Comparison of antibiotic susceptibility of Escherichia coli in urinary isolates from an emergency department with other institutional susceptibility data. Am J Health Syst Pharm. 2015;72:2176–80. https://doi.org/10.2146/ajhp140832.

    Article  PubMed  CAS  Google Scholar 

  15. Cai T, Nesi G, Mazzoli S, Meacci F, Lanzafame P, Caciagli P, et al. Asymptomatic bacteriuria treatment is associated with a higher prevalence of antibiotic resistant strains in women with urinary tract infections. Clin Infect Dis. 2015;61:1655–61. https://doi.org/10.1093/cid/civ696.

    Article  PubMed  CAS  Google Scholar 

  16. Duffy MA, Hernandez-Santiago V, Orange G, Davey PG, Guthrie B. Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis. Br J Gen Pract. 2013;63:e238–43. https://doi.org/10.3399/bjgp13X665198.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis. 2008;47:1150–8. https://doi.org/10.1086/592250.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Florian Hitzenbichler.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hitzenbichler, F., Simon, M., Holzmann, T. et al. Antibiotic resistance in E. coli isolates from patients with urinary tract infections presenting to the emergency department. Infection 46, 325–331 (2018). https://doi.org/10.1007/s15010-018-1117-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-018-1117-5

Keywords

Navigation